What does a polypoid area in the terminal ileum indicate in a patient?

Polypoid Area in the Terminal Ileum: Clinical Significance

A polypoid area in the terminal ileum requires systematic evaluation to distinguish between inflammatory bowel disease (particularly Crohn's disease), infectious causes, benign polyps, and neoplastic lesions, with the diagnostic approach guided by patient history, endoscopic characteristics, and histopathology. 1

Primary Differential Diagnoses

Inflammatory Bowel Disease

• Crohn's disease is the most common cause of terminal ileal pathology, characterized by transmural inflammation that frequently affects this location 1
• The terminal ileum should be biopsied during ileocolonoscopy with at least two specimens taken to establish diagnosis 2
• Histological features of Crohn's disease include focal (discontinuous) chronic inflammation, transmural involvement, and non-crypt-related granulomas 1
• Polypoid dysplasia can occur in IBD patients and requires distinction from sporadic adenomas, as management differs significantly 3, 4

Infectious Etiologies

• Yersinia, Salmonella, Shigella, Campylobacter species, and Cytomegalovirus can cause terminal ileal ulceration and polypoid changes, particularly in immunocompromised patients 1
• Clinical history of acute symptoms, fever, and travel should prompt consideration of infectious causes 2

Benign Lesions

• Inflammatory fibroid polyps are rare benign tumors that can occur in the terminal ileum and may cause intussusception or obstruction 5
• Hyperplastic polyps, though more common in the stomach and colon, can occasionally occur in the small bowel 6

Diagnostic Approach

Endoscopic Evaluation

• Ileocolonoscopy with targeted biopsies is essential, taking specimens from both the lesion and surrounding mucosa 2, 1
• Document the morphology of the polypoid lesion: sessile (broad-based), pedunculated (with stalk), or flat (height <3mm) 2
• Measure maximum diameter in millimeters with annotated images 2
• Assess for additional features: ulceration, surrounding inflammation, friability, or multiple lesions 2

Cross-Sectional Imaging

• CT or MR enterography should be performed to assess extent of disease, particularly if Crohn's disease is suspected 2
• Severe inflammation is characterized by wall thickening of 3-5mm, presence of ulcerations, or high T2 intramural signal 1
• Imaging can identify complications such as strictures, fistulas, or abscesses that would not be apparent endoscopically 2

Histopathological Assessment

• Biopsies must be accompanied by full clinical details including symptom duration, endoscopic findings, and any relevant medical history 2
• Key features to assess include:
  • Chronic architectural changes (crypt distortion, atrophy, basal plasmacytosis) suggesting IBD 2
  • Granulomas (non-caseating, non-crypt-related) supporting Crohn's disease 1
  • Dysplasia grading if IBD is present, as this determines management 2, 3
  • Infectious organisms or specific inflammatory patterns 1

Management Implications Based on Diagnosis

If Crohn's Disease-Related

• Polypoid lesions in the context of active Crohn's disease represent inflammatory pseudopolyps or dysplasia-associated lesions 3, 4
• Polypoid dysplasia arising within areas of colitis requires complete excision if possible, with continued surveillance if margins are clear and no flat dysplasia exists elsewhere 2, 3
• Non-polypoid dysplasia or unresectable polypoid dysplasia warrants colectomy regardless of dysplasia grade 2

If Sporadic Adenoma

• Polyps occurring proximal to segments with IBD involvement are considered sporadic adenomas and managed with standard polypectomy 2
• For pedunculated polyps >10mm, hot snare polypectomy is recommended 7
• Ensure adequate resection margins (at least 2mm if malignancy suspected) 7

If Inflammatory Fibroid Polyp or Obstructing Lesion

• Surgical resection is indicated if the lesion causes obstruction or intussusception 5
• Endoscopic polypectomy may be attempted for smaller, accessible lesions 6

Critical Pitfalls to Avoid

• Do not assume all polypoid lesions in the terminal ileum are benign—dysplasia in IBD patients has significant malignant potential 2, 4
• Distinguish between IBD-associated polypoid dysplasia and sporadic adenomas, as the former has a 7.5% risk of developing adenocarcinoma at follow-up versus minimal risk for the latter 4
• Longer disease duration (>10 years), tubulovillous architecture, and admixture of normal and dysplastic epithelium suggest IBD-associated dysplasia rather than sporadic adenoma 4
• Always obtain biopsies from both the lesion and surrounding mucosa to assess for flat dysplasia elsewhere, which would change management from polypectomy to colectomy 2
• Consider repeat examination with high-definition endoscopy and chromoendoscopy if dysplasia is found on random biopsies, as many "invisible" dysplastic lesions are actually subtle visible lesions 2